Article
Factor VIII inhibitors.
Current opinion in hematology - 1 Sept 1995
Hoyer L W
Abstract excerpt
The development of a Factor VIII inhibitor, an antibody that blocks its procoagulant function, is one of the most serious complications of hemophilia A treatment. Similar antibodies are also recognized as a rare cause of bleeding in previously healthy individuals who develop autoimmune anti-Factor VIII antibodies. Recent studies have yielded important information about these antibodies in four different areas:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.